[go: up one dir, main page]

BRPI0820798A2 - Uso de pelo menos um composto, e produtos - Google Patents

Uso de pelo menos um composto, e produtos

Info

Publication number
BRPI0820798A2
BRPI0820798A2 BRPI0820798-4A BRPI0820798A BRPI0820798A2 BR PI0820798 A2 BRPI0820798 A2 BR PI0820798A2 BR PI0820798 A BRPI0820798 A BR PI0820798A BR PI0820798 A2 BRPI0820798 A2 BR PI0820798A2
Authority
BR
Brazil
Prior art keywords
products
compound
Prior art date
Application number
BRPI0820798-4A
Other languages
English (en)
Inventor
Dominique Mazier
Nassira Mahmoudi
Khémaïs Farhati
Ramon Garcia-Domenech
Jorge Galvez
Francis Derouin
Martin Danis
Original Assignee
Université Pierre Et Marie Curie Paris 6
Univ Paris Diderot Paris 7
Univ Valencia
Assistance Publique Hospitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université Pierre Et Marie Curie Paris 6, Univ Paris Diderot Paris 7, Univ Valencia, Assistance Publique Hospitaux De Paris filed Critical Université Pierre Et Marie Curie Paris 6
Publication of BRPI0820798A2 publication Critical patent/BRPI0820798A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BRPI0820798-4A 2007-12-11 2008-12-11 Uso de pelo menos um composto, e produtos BRPI0820798A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07291487A EP2070522A1 (en) 2007-12-11 2007-12-11 Compounds for preventing and treating plasmodium infections.
PCT/EP2008/067328 WO2009074649A1 (en) 2007-12-11 2008-12-11 Compounds for preventing and treating plasmodium infections

Publications (1)

Publication Number Publication Date
BRPI0820798A2 true BRPI0820798A2 (pt) 2015-06-16

Family

ID=39768886

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0820798-4A BRPI0820798A2 (pt) 2007-12-11 2008-12-11 Uso de pelo menos um composto, e produtos

Country Status (7)

Country Link
US (1) US20110124723A1 (pt)
EP (2) EP2070522A1 (pt)
JP (1) JP2011506398A (pt)
AU (1) AU2008334620A1 (pt)
BR (1) BRPI0820798A2 (pt)
CA (1) CA2709232A1 (pt)
WO (1) WO2009074649A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2952823B1 (fr) * 2009-10-30 2012-04-20 Sanofi Aventis Utilisation de la ferroquine dans le traitement ou la prevention du paludisme
US8822528B2 (en) 2010-11-16 2014-09-02 Merial Limited Monensin derivatives for the treatment and prevention of protozoal infections
TW202030333A (zh) * 2018-12-20 2020-08-16 美商簡 探針公司 用於檢測瘧原蟲物種核酸之組成物及方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294925A (en) 1979-09-20 1981-10-13 Hoffmann-La Roche Inc. Monensin urethane derivatives produced by streptomyces

Also Published As

Publication number Publication date
EP2231135A1 (en) 2010-09-29
WO2009074649A1 (en) 2009-06-18
CA2709232A1 (en) 2009-06-18
US20110124723A1 (en) 2011-05-26
AU2008334620A1 (en) 2009-06-18
JP2011506398A (ja) 2011-03-03
EP2070522A1 (en) 2009-06-17

Similar Documents

Publication Publication Date Title
BRPI1005322A2 (pt) anticorpo, composição farmacêutica e uso de pelo menos um anticorpo
BRPI0811635A2 (pt) Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
BRPI0908097A2 (pt) uso de pelo menos um composto, peptídeo, e, formulação farmacêutica.
BRPI0815709A2 (pt) composro, composição farmacêutica, e, uso de um composto.
BRPI0915137A2 (pt) uso de pelo menos um composto, peptídeo, e, formulação farmacêutica
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0810696A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0915136A2 (pt) uso de pelo menos um composto, peptídeo, e, formulação farmacêutica
BRPI0813770A2 (pt) Composição, e, uso de uma composição
BRPI0915134A2 (pt) composto, e, uso de um composto
BRPI0716171A2 (pt) composto, composiÇço farmacÊutica e uso de um composto.
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0907453A2 (pt) Compostos, uso e preparação dos mesmos
BRPI0716327A2 (pt) Composto de fenilpropionamida e uso
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BRPI0812942A2 (pt) Composto, composição farmacêutica e uso de um composto
BRPI0810019A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.